# Project Execution State

**Last updated:** 2026-05-11
**Phase:** Phase 4 — Benchmarking memo (in progress); Phase 3 complete
**Status:** All 7 dossiers complete and committed (`780504a`). Phase 4 dispatching 8 parallel case-study subagents.
**Next action:** Await Phase 4 completion, synthesize benchmarking memo, then Phase 5 tactical artifacts (cheat sheets, cross-reference matrix, intro network map), then Phase 6 playbook, then Phase 7 exec summary + deck.

---

## How to resume in a fresh session

If this session ended (token reset, context overflow, deliberate stop), a fresh Claude session can pick up here:

1. `cd /Users/marksenerth/_src/eldridge_research`
2. Read this `STATE.md` to see what's done and what's next
3. Read the plan: `docs/superpowers/plans/2026-05-10-nuvance-fundraising-implementation.md`
4. Read the spec for context: `docs/superpowers/specs/2026-05-10-nuvance-fundraising-strategy-design.md`
5. Run `git log --oneline` to see exactly which commits are in (each task commits with a descriptive message)
6. Continue from "Next action" above using the same subagent-driven-development + parallelization approach

**Critical context for resuming Claude:**
- We're executing the implementation plan using `superpowers:subagent-driven-development` + parallel dispatch per the plan's Parallelization Strategy section
- Five checkpoints (A, B, C, D, E) pause for Mark's human review; never proceed past a checkpoint without explicit approval
- Each plan task references self-contained Appendix templates (A, B, C) — subagents read those to do their work independently
- Quality standards: every claim cited, triangulated against ≥2 sources, confidence-labeled (known/inferred/unknown)
- Source-index conflict resolution: parallel subagents do NOT commit; they write artifact files, orchestrator commits after batch completes

---

## Completed tasks

- ✅ **Brainstorming complete** — spec written and approved
- ✅ **Plan written** — committed at `2d96c9e`
- ✅ **Task 0.1** — Project directory setup, source_index.md created, committed at `4984442`
- ✅ **Batch 0.A** — 4 parallel artifacts produced, committed at `53f9a97`
  - ⚠️ Web access (WebFetch/WebSearch) was denied to all four subagents; artifacts are training-data-based.
- ✅ **Live-web verification pass** — orchestrator used WebSearch/WebFetch in main session to verify top 10+ Phase 0 facts. Authoritative findings saved to `sources/phase_0_verification_update.md`, committed at `fcf6160`. This file supersedes any conflicting claim in the 4 training-data artifacts.

## Most important verification corrections (see verification update for full sourcing)
- Northwell-Nuvance merger **COMPLETE** May 2026 (subagents thought "pending")
- Murphy retired Dec 2025; Robertson is market president; D'Angelo is system CEO
- Robert R. Dyson is **ALIVE** (subagent reported deceased — wrong)
- Dyson Foundation historical scale is $1M-tier (not transformational); strategy must recalibrate
- Vassar Brothers Patient Pavilion ($550M, 2021) appears **unnamed** — potentially the single most consequential unsold naming opportunity
- Whittingham family confirmed top Phase 1 prospect ($4.5M cumulative since 1997, multi-generational)
- Laura Eldridge is "Senior Director, Development & Planned Giving" (NOT Foundation president)
- $1B Northwell capital investment over 5 years = real capital pipeline

## Critical findings from Batch 0.A (preview)

- **Northwell affiliation/acquisition** is the dominant strategic context (Feb 2024 announce, ~2025 close); materially reshapes case-for-support
- **Nuvance entered the deal from financial weakness** ($130-200M operating losses FY22-23, credit downgrades, layoffs)
- **Dyson family/Foundation** — top Phase 1 lead (named Dyson Center for Cancer Care at Vassar Brothers; Robert Rogers Dyson died 2024 → succession window)
- **Vassar family** genealogical question — single highest-leverage open question of the project
- **No $100M+ named opportunity exists** at Nuvance currently; no peer-tier signature program (Smilow/Bennett/Schwab equivalent). Case-for-support audit will recommend institutional repositioning as precondition for a credible $500M campaign.
- **Realistic strategy framing:** $75-200M over 3-5 years from 3-5 transformational gifts is plausible; the full $500M aspiration is 12-30x current baseline and requires institutional moves not yet visible.
- **Donor base is regional, not national:** three clusters — Dutchess multigenerational families, Fairfield grateful-patient executives, Litchfield weekenders. Affinity-first calibration is strongly ratified.

- ✅ **Task 0.6: Case-for-support audit** — synthesis complete, committed at `d993db4`. Verdict: Nuvance does not currently sustain $500M case. Three institutional recommendations: (1) resolve VBMC Pavilion naming 60 days, (2) define one signature institute by end FY2026 with $50M founding-donor opportunity, (3) publicly allocate the $1B Northwell capital commitment to year-1 anchor projects.
- ✅ **Checkpoint A** — completed. Scope tightened to 5-7 final candidates, web access enabled via curated allowlist (~30 domains), Laura's title corrected to AVP Development, source rigor codified.
- ✅ **Phase 1 Task 1.1: Screening methodology** — committed at `cae603e`. Reflects scope refinement and Phase 0 priors.

- ✅ **Phase 1 Batch 1.B** — 5 parallel screens complete, committed at `e993e71`. Subagents hit rate limit during return-to-orchestrator but all files were written to disk before limit. Recovered.
- ✅ **Phase 1 aggregation + Batch 1.C (orchestrator-consolidated)** — committed at `b9b31bc`. Orchestrator-led affinity scoring saved a parallel-subagent dispatch; long_list.md complete with 10-12 ADVANCE + 6-8 HOLD candidates.
- ✅ **Whittingham correction** — Phase 0 verification update §5 corrected (Andrew d. Feb 2021, Michael predeceased; current principals Adam + Robyn).

## Critical Phase 1 findings (preview for Checkpoint B)

- **George & Carol Bauer** — TOP PRIORITY. $35M+ Norwalk Hospital lead donor, age 95, succession-imminent. Invisible to Phase 0.
- **Robert R. Dyson** — score 26/30. Multi-decade Vassar Brothers benefactor; foundation $246.9M; transformational ask requires escalation from $1M-tier history.
- **Ray Dalio** — score 26/30. Already active Nuvance donor ($5.1M June 2025); Bridgewater exit complete = peak life-stage signal.
- **Whittingham family** — score 23/30 BUT lower wealth tier than Phase 0 assumed. Transformational potential $1-10M, not $25M+.
- **Michael Rees** — Feinstein/Northwell board insider; mid-career.
- **Amy Goldman Fowler** — Rhinebeck NY core service area but cause-affinity gap.
- **Jasper Johns** — Sharon CT, $217M Low Road Foundation, age 95, blue-sky.
- **Greenwich/Stamford hedge fund corridor** is densely NYP/MSK/Mt Sinai-loyal — Phase 0 audit verdict reinforced.

- ✅ **Checkpoint B** — Mark approved 7-candidate short list. Committed at `2d3d758`.

- ✅ **Phase 3: 7 deep dossiers complete** — committed at `780504a`. ~60KB each. All web-verified with source citations.

## Top Phase 3 strategic findings (preview)

- **Bauer:** USAmeriBancorp $816M sale 2018 is wealth source; 3 children identified (Jocelyn, Jennifer, Brad); Jeffrey Peter Bauer (son d. 5 days old early 1960s) is Repayer anchor; Carol is certified chaplain. $5-15M ask via Peter Cordeau, ~12-24 month window.
- **Dyson:** Rob served on Health Quest Systems board (parent of Vassar Brothers pre-merger) — major affinity upgrade to 28/30. Anne E. Dyson (sister d. 2000 breast cancer) = endowed-chair Repayer opportunity. $10-25M via Andrea L. Reynolds (Foundation CEO).
- **Dalio:** STRUCTURAL ISSUE — June 2025 $5.1M routed through CHRO not Foundation; Laura must integrate before June 2026 milestone. $25-50M Dalio Health Equity Institute escalation pathway.
- **Whittingham:** C. Anthony's wealth source: U.S. Surgical → Joint Medical Products → Johnson & Johnson 1995. Both G2 brothers deceased (Michael Oct 2020, Andrew Feb 2021). $3-7M realistic, not $25M.
- **Rees:** Wife Allison volunteers Northwell directly; March 2026 estate transfer = 18-36 month window (not 10+ years). $10-25M Feinstein-linked via Kevin J. Tracey.
- **Goldman Fowler:** TRANSFORMATIONAL FINDING — first cousin Lloyd Goldman is largest single donor in Northwell history ($100M+). Activates dramatic warm path. $5-25M for Goldman/Fowler Women's Health Center in unnamed Pavilion. Risk: active sibling litigation.
- **Jasper Johns:** Estate plan locked-in (Low Road Sharon Inc. artist residency); no family heirs. $1-5M conditional, hard 4-month decision gate.

## In progress

- 🔄 **Phase 4: 8 parallel benchmarking subagents** — case studies on: Cohen Children's at Northwell, Mt Sinai Icahn, Yale-NHH Smilow, Greenwich Hospital, Hartford Ayer Neuroscience, HSS specialty institute, Northern Westchester Schwartz Northwell, Lloyd Goldman at Lenox Hill.

## Recommended next steps post-dossiers

- Run cross-dossier consistency review (Task 3.4 per implementation plan)
- Optionally dispatch Phase 4 (benchmarking memo, 8-12 case studies) in parallel with finishing Phase 3 work
- Phase 5 tactical artifacts (warm-intro network map, per-candidate cheat sheets, cross-reference matrix) depend on dossiers complete
- Phase 6 strategy playbook synthesis depends on Phases 0-5
- Phase 7 executive summary + designed deck is final synthesis

## Phase 1 scope refinement (committed at `cae603e` in screening_methodology.md)

- Final candidate target: 5-7 (was 10)
- Long-list target: 25-40 (was 40-60)
- Wealth-tier calibration shifted: ~70-80% centi-millionaires
- Affinity-first emphasized given Northwell-merger competitive context
- Phase 0 priors incorporated (Whittingham, Dyson, HV grandee corridor, Greenwich hedge fund cohort, Vassar College alumni network)
- Source rigor codified as hard standard

## Web access enabled

Project-level settings.local.json populated with ~30 research domains. Subagents can WebFetch the allowed domains directly; new domains auto-add when first used (with permission prompt that may need user attention).

## Pending — Phase 0

- ⏸ Task 0.6: Case-for-support audit (sequential after Batch 0.A) — synthesis task, less web-dependent
- 🛑 Checkpoint A: Halt for Mark's review

## Pending — later phases

See plan file for full sequence. Phase order: 0 → 1 → 2 → 3 (parallel with 4) → 5 → 6 → 7.

---

## Update protocol

After every task or batch completes, the orchestrator updates this file with:
- New "Last updated" timestamp
- Move tasks from "In progress" → "Completed" with commit SHA
- Update "Next action"
- Commit the change with message: `STATE: <one-line summary of progress>`

This is the resumability backbone. **Never let it go stale.**
